|
|
| CAT 2200 / AstraZeneca (0 Trials) |
|
| CAT-179 / Catamaran Bio (0 Trials) |
|
| CAT-2003 / Astria Therap (0 Trials) |
|
| CAT-248 / Catamaran Bio (0 Trials) |
|
| CAT-4001 / Astria Therap (0 Trials) |
|
| CAT-5571 / Astria Therap (0 Trials) |
|
| Cat-SPIRE / Circassia (0 Trials) |
|
| CAT6001 / AstraZeneca (0 Trials) |
|
| Cataclot (ozagrel) / Ono Pharma (1 Trials) |
|
| Catalin (pirenoxine) / Senju (0 Trials) |
|
| catastrophic pediatric epilepsy therapeutic / Marathon (0 Trials) |
|
| Catena (idebenone) / Chiesi (3 Trials) |
|
| Cathepsin A inhibitor / EVER Pharma (0 Trials) |
|
| cathepsin K inhibitors / Oncotelic (0 Trials) |
|
| cathepsin L inhibitors / Oncotelic (0 Trials) |
|
| Cationorm / Yissum Research Development Company, Santen (2 Trials) |
|
| Catioprost (latanoprost emulsion) / Santen (1 Trials) |
|
| Caumz (cannabidiol/delta 9 tetrahydrocannabinol) / Tetra Bio-Pharma (0 Trials) |
|
| Cavaltinib / Naturally Splendid (0 Trials) |
|
| Cavatak (gebasaxturev) / Merck (MSD) (2 Trials) |
|
| Cavoley (pegfilgrastim biosimilar) / Gedeon Richter, Stada (0 Trials) |
|
| cavosonstat (PBA-003) / Laurel Therap, Path BioAnalytics (3 Trials) |
|
| cavrotolimod (AST-008) / Exicure (1 Trials) |
|
| Cayston (aztreonam lysine) / Gilead (3 Trials) |
|
| CB 2679-GT / GC Biopharma (0 Trials) |
|
| CB 2782 / Catalyst Biosci (0 Trials) |
|
| CB 4332 / Vertex (0 Trials) |
|
| CB 5300 / Canopus BioPharma (0 Trials) |
|
| CB CAR-NK019 / Zhejiang University (0 Trials) |
|
| CB-01-12 / Cosmo Pharma (0 Trials) |
|
| CB-010 / Caribou Biosci (0 Trials) |
|
| CB-011 / Caribou Biosci (0 Trials) |
|
| CB-012 / Cidara Therap (0 Trials) |
|
| CB-012 / Caribou Biosci (0 Trials) |
|
| CB-020 / Caribou Biosci (0 Trials) |
|
| CB-0406 / CymaBay (0 Trials) |
|
| CB-101 / Curyx Bio (0 Trials) |
|
| CB-103 / Cellestia Biotech (0 Trials) |
|
| CB-280 / Calithera (0 Trials) |
|
| CB-5083 / Cleave Therap (0 Trials) |
|
| CB-5339 / CASI (0 Trials) |
|
| CB-668 / Calithera (0 Trials) |
|
| CB-AC-02 / CHA Bio & Diostech (0 Trials) |
|
| CB-MSC-1 / Avalon GloboCare (0 Trials) |
|
| CB-NK-TGF-βR2-/NR3C1 / UT MD Anderson Cancer Center (0 Trials) |
|
| CB001 / Fox Chase Cancer Center (0 Trials) |
|
| CB002 / Fox Chase Cancer Center, Pennsylvania State University (0 Trials) |
|
| CB03 / Zhimeng Biopharma (0 Trials) |
|
| CB0306 / Cennerv Pharma (0 Trials) |
|
| CB06 / Zhimeng Biopharma (0 Trials) |
|
| CB1-SSi / Aelis Farma (0 Trials) |
|
| CB101 / Cantabio Pharma (0 Trials) |
|
| CB2009 / Canopus BioPharma (0 Trials) |
|
| CB201 / Crescendo Biologics (0 Trials) |
|
| CB213 / Crescendo Biologics (0 Trials) |
|
| CB2202 / Cennerv Pharma (0 Trials) |
|
| CB2233 / Cennerv Pharma (0 Trials) |
|
| CB2810 / Cennerv Pharma (0 Trials) |
|
| CB301 / Cantabio Pharma (0 Trials) |
|
| CB307 / Crescendo Biologics (0 Trials) |
|
| CB401 / Cantabio Pharma (0 Trials) |
|
| CB4209 / CohBar (0 Trials) |
|
| CB4211 / CohBar (0 Trials) |
|
| CB5064 analog / CohBar (0 Trials) |
|
| CB5138-1 / CohBar (0 Trials) |
|
| CB5138-2 / CohBar (0 Trials) |
|
| CB5138-3 / CohBar (0 Trials) |
|
| CB693 / Crescendo Biologics (0 Trials) |
|
| CBA-1535 / Chiome Biosci (0 Trials) |
|
| CBG-002 / Carbiogene Therap (0 Trials) |
|
| CBG-006 / Carbiogene Therap (0 Trials) |
|
| CBIO-007 / Chimera Bioengineering (0 Trials) |
|
| CBIS SSA-001 / Cannabis Science (0 Trials) |
|
| CBIS-LC-001 / Cannabis Science (0 Trials) |
|
| CBIS-PC-001 / Cannabis Science (0 Trials) |
|
| CBIS-PTSD-001 / Cannabis Science (0 Trials) |
|
| CBIS-SD-001 / Cannabis Science (0 Trials) |
|
| CBL 1155 / Cerylid Biosci (0 Trials) |
|
| CBL 316 / Cerylid Biosci (0 Trials) |
|
| CBL0137 IA / Incuron, Statera BioPharma (0 Trials) |
|
| CBL137 IV / Incuron (1 Trials) |
|
| CBLB612 / Statera BioPharma (0 Trials) |
|
| CBM-C20.1 / Cellular Biomedicine (1 Trials) |
|
| CBO421 / Cidara Therap (0 Trials) |
|
| CBP-1008 / Coherent Biopharma (0 Trials) |
|
| CBP-1018 / Coherent Biopharma (0 Trials) |
|
| CBP-1019 / Coherent Biopharma (0 Trials) |
|
| CBP-1029 / Coherent Biopharma (0 Trials) |
|
| CBP-1039 / Coherent Biopharma (0 Trials) |
|
| CBP-174 / Suzhou Connect Biopharma (0 Trials) |
|
| CBP-233 / Suzhou Connect Biopharma (0 Trials) |
|
| CBP501 / CanBas (1 Trials) |
|
| CBS-3595 / c-a-i-r biosciences (0 Trials) |
|
| CBS001 / Centessa (0 Trials) |
|
| CBT-001 / Cloudbreak Therap (0 Trials) |
|
| CBT-004 / Cloudbreak Therap (0 Trials) |
|
| CBT-005 / Cloudbreak Therap (0 Trials) |
|
| CBT-006 / Cloudbreak Therap (0 Trials) |
|
| CBT-1 (tetrandrine) / CBA Pharma (2 Trials) |
|
| CBT-103 / Cellective BioTherapy (0 Trials) |
|
| CBT-107 / Cellective BioTherapy (0 Trials) |
|
| CBT-1401A / Centeer BioTherap (0 Trials) |
|
| CBT-1405B / Centeer BioTherap (0 Trials) |
|
| CBT101 / CHA Bio & Diostech (0 Trials) |
|
| CBT124 (bevacizumab biosimilar) / Cipla, Bio Mabs (1 Trials) |
|
| CBX-11 / Cybrexa Therap (0 Trials) |
|
| CBX-13 / Cybrexa Therap (0 Trials) |
|
| CBX-14 / Cybrexa Therap (0 Trials) |
|
| CBX-15 / Cybrexa Therap (0 Trials) |
|
| CC 10015 / BMS (0 Trials) |
|
| CC 11006 / BMS (0 Trials) |
|
| CC-0739623 / BMS (0 Trials) |
|
| CC-1 / University Hospital Tuebingen (0 Trials) |
|
| CC-115 / BMS (0 Trials) |
|
| CC-414 / Clear Creek Bio (0 Trials) |
|
| CC-42344 / Cocrystal Pharma (0 Trials) |
|
| CC-671 / BMS (0 Trials) |
|
| CC-700C / TCM Biotech (0 Trials) |
|
| CC-90002 / Inhibrx, BMS (0 Trials) |
|
| CC-90003 / BMS (0 Trials) |
|
| CC-90005 / BMS (0 Trials) |
|
| CC-90006 / BMS (1 Trials) |
|
| CC-91633 / BMS (0 Trials) |
|
| CC-92252 / BMS (0 Trials) |
|
| CC-92328 / BMS (0 Trials) |
|
| CC-96191 / BMS (0 Trials) |
|
| CC100 / Chemigen (0 Trials) |
|
| cccDNA epigenetic modifiers / Arbutus (0 Trials) |
|
| cccDNA formation inhibitors / Baruch S. Blumberg Institute, Arbutus (0 Trials) |
|
| CCI-001 / PharmaMatrix Holdings (0 Trials) |
|
| CCI15106 / GSK (0 Trials) |
|
| CCP-08 / Tris Pharma, HitGen (0 Trials) |
|
| CCP-08 / Tris Pharma, HitGen (0 Trials) |
|
| CCR4 antagonist / Amgen (0 Trials) |
|
| CCR5 antagonist / Amgen (0 Trials) |
|
| CCR5-001 / Cidara Therap (0 Trials) |
|
| CCT128930 / Otsuka (0 Trials) |
|
| CCT129202 / Chroma Therap (0 Trials) |
|
| CCT137690 / Chroma Therap, Institute of Cancer Research (0 Trials) |
|
| CCT196969 / The University of Manchester, Institute of Cancer Research (0 Trials) |
|
| CCT241161 / The University of Manchester, Institute of Cancer Research (0 Trials) |
|
| CCT244747 / Sareum (0 Trials) |
|
| CCT301-38 / Sunterra Biotech, Exuma Biotech (0 Trials) |
|
| CCT301-59 / Sunterra Biotech, Exuma Biotech (0 Trials) |
|
| CCT303-406 / Sunterra Biotech, Exuma Biotech (0 Trials) |
|
| CCW702 / AbbVie (0 Trials) |
|
| CCX-025 / Amgen (0 Trials) |
|
| CCX140 / Amgen, CSL Behring (1 Trials) |
|
| CCX354 / Amgen (0 Trials) |
|
| CCX4503 / Amgen (0 Trials) |
|
| CCX507 / Amgen (0 Trials) |
|
| CCX559 / Amgen (0 Trials) |
|
| CCX587 / Amgen (0 Trials) |
|
| CCX6239 / Amgen (0 Trials) |
|
| CCX634 / Amgen (0 Trials) |
|
| CCX650 / Amgen (0 Trials) |
|
| CCX832 / GSK, Amgen (0 Trials) |
|
| CCX872 / Amgen (0 Trials) |
|
| CCX9588 / Amgen (0 Trials) |
|
| CD 650 / Chodang Pharm (0 Trials) |
|
| CD therapeutics / Deltagen (0 Trials) |
|
| CD123 CAR T-cell therapy / Tianjin First Central Hospital (0 Trials) |
|
| CD123 CAR-T cell therapy / Chongqing Precision Biotech (0 Trials) |
|
| CD123-CAR T cell therapy / St. Jude Children's Research Hospital (0 Trials) |
|
| CD123R(EQ)28zeta/EGFRt+ T cells / National Cancer Institute (1 Trials) |
|
| CD133-specific CAR-T cell therapy / Century Therap (0 Trials) |
|
| CD137 mAb / LFB SA (0 Trials) |
|
| CD137/FAP agonist / Boehringer Ingelheim (0 Trials) |
|
| CD147-CAR T cells / Peking University People's Hospital (0 Trials) |
|
| CD147-CART / Air Force Medical University (0 Trials) |
|
| CD16xCD33 BiKE / GT Biopharma (0 Trials) |
|
| CD19 and CD22 targeted prime CAR-T / Chongqing Precision Biotech (0 Trials) |
|
| CD19 CAR T cells / City of Hope, National Cancer Institute (0 Trials) |
|
| CD19 CAR-T / Pregene Biotech (0 Trials) |
|
| CD19 CAR-T cell immunotherapy / Lonza, Sheba Medical Center (0 Trials) |
|
| CD19 CAR-T cell therapy for CLL & ALL / TheraVectys (0 Trials) |
|
| CD19 CAR-T cells / Z-park Sanly Regenerative Medicine Research Centre (0 Trials) |
|
| CD19 CAR-T cells therapy / Jibei Biotech (0 Trials) |
|
| CD19 specific CAR T cell therapy / Baylor Scott & White Research Institute (3 Trials) |
|
| CD19 targeted CAR-T / Southwest Hospital (1 Trials) |
|
| CD19 TriTAC-XR / Merck (MSD) (0 Trials) |
|
| CD19 UCAR-T / Suzhou Maximum Bio-tech (0 Trials) |
|
| CD19 UCART cells / China Biotech Services (0 Trials) |
|
| CD19 Universal CARvac NK cells / iCell Gene Therap (0 Trials) |
|
| CD19 Universal Chimeric Antigen Receptor T Cell / Suzhou Maximum Bio-tech (0 Trials) |
|
| CD19-7×19 CAR-T / Zhejiang University (0 Trials) |
|
| CD19-ATAC / Heidelberg Pharma (0 Trials) |
|
| CD19-BCMA CAR-T cell therapy / Shanghai Ultra-T Immune Therap (0 Trials) |
|
| CD19-BCMA UCAR-T / Suzhou Maximum Bio-tech (0 Trials) |
|
| CD19-CAR-DNT / Ruichuang Bio, Zhejiang Ruijiamei Biotech (0 Trials) |
|
| CD19-CAR-T ProTcell / Smart Immune, Memorial Sloan-Kettering Cancer Center (0 Trials) |
|
| CD19-CAR-T2 cells / Southern Medical University (0 Trials) |
|
| CD19-CAR.CD45RA- negative T-cells / St. Jude Children's Research Hospital (0 Trials) |
|
| CD19-CAR_Lenti T cells / Bambino Gesu Hospital (0 Trials) |
|
| CD19-CART / PersonGen Biomedicine (0 Trials) |
|
| CD19-CD22 CAR-T / Shanghai Ultra-T Immune Therap (0 Trials) |
|
| CD19-CD22 CAR-T / Shanghai Keqi Pharma (0 Trials) |
|
| CD19-CD34 CAR transduced T cells / Loyola University (0 Trials) |
|
| CD19-CD34t metabolically programmed CAR transduced T-cells / Medical University of South Carolina (0 Trials) |
|
| CD19-PD1-CART cell / Chinese PLA General Hospital (0 Trials) |
|
|